Revance Therapeutics Debt 2024

Revance Therapeutics Aktienanalyse

What does Revance Therapeutics do?

Revance Therapeutics Inc is a US-based biopharmaceutical company that specializes in the development and marketing of novel treatments in dermatology, neurology, and aesthetic medicine. The company was founded in 2002 and is headquartered in Newark, California. Translated: Revance Therapeutics Inc is a US-based biopharmaceutical company that specializes in the development and marketing of novel treatments in dermatology, neurology, and aesthetic medicine. The company was founded in 2002 and is headquartered in Newark, California. Revance Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Revance Therapeutics's Debt Structure

Revance Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Revance Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Revance Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Revance Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Revance Therapeutics stock

What is the debt of Revance Therapeutics this year?

Revance Therapeutics has a debt level of 294.42 USD this year.

What was the debt of Revance Therapeutics compared to the previous year?

The debt of Revance Therapeutics has increased by 8.64% compared to the previous year increased.

What are the consequences of high debt for investors in Revance Therapeutics?

High debt can pose a risk for investors of Revance Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Revance Therapeutics?

Low debt means that Revance Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Revance Therapeutics affect the company?

An increase in debt of Revance Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Revance Therapeutics affect the company?

A reduction in debt of Revance Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Revance Therapeutics?

Some factors that can influence the debt of Revance Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Revance Therapeutics so important for investors?

The debts of Revance Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Revance Therapeutics take to change the debt?

To change the debt, Revance Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Revance Therapeutics pay?

Over the past 12 months, Revance Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Revance Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Revance Therapeutics?

The current dividend yield of Revance Therapeutics is .

When does Revance Therapeutics pay dividends?

Revance Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Revance Therapeutics?

Revance Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Revance Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Revance Therapeutics located?

Revance Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Revance Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Revance Therapeutics from 7/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did Revance Therapeutics pay the last dividend?

The last dividend was paid out on 7/16/2024.

What was the dividend of Revance Therapeutics in the year 2023?

In the year 2023, Revance Therapeutics distributed 0 USD as dividends.

In which currency does Revance Therapeutics pay out the dividend?

The dividends of Revance Therapeutics are distributed in USD.